Monogenic Diabetes Misdiagnosed as Type 1
This research is looking into a common problem: people being told they have Type 1 diabetes when they actually have a less common type called monogenic diabetes. Monogenic diabetes is caused by changes in a single gene, and it's often treated differently from Type 1 diabetes. The study will analyse blood samples from thousands of young people diagnosed with Type 1 diabetes to see if they lack certain markers typical of Type 1. If so, they'll check their genes for monogenic diabetes. They also want to identify factors that can help doctors tell the difference between these types of diabetes more easily. Finally, the study hopes to find entirely new genes that cause monogenic diabetes, which could improve diagnosis and care for future patients.
De un vistazo
¿De qué trata este estudio?
This research study is about a type of diabetes called monogenic diabetes. Unlike Type 1 diabetes, which is an autoimmune condition, monogenic diabetes is caused by a change in a single gene. The important thing is that monogenic diabetes is often mistaken for Type 1 diabetes, especially in younger people. This can be a problem because the treatment for monogenic diabetes can be very different, and sometimes people can even switch from insulin injections to tablets if they have the correct diagnosis.
The study has two main goals. Firstly, it wants to find out just how often monogenic diabetes is confused with Type 1 diabetes in young people across Canada. It also aims to create a clearer guide or 'algorithm' to help doctors identify who might have monogenic diabetes rather than Type 1. Secondly, the researchers hope to discover entirely new genes that cause monogenic diabetes. Finding new genes is crucial because it helps us understand the disease better and can lead to improved diagnostic tests and more targeted treatments in the future.
To achieve this, the researchers will be looking at health information and gene tests from many young people who were diagnosed with diabetes before the age of 25. By carefully examining their genetic makeup, especially for those who don’t show the usual signs of Type 1 diabetes, they hope to shed light on this often-misunderstood condition and ultimately improve care for those affected.
Puntos clave
- This study helps understand why some people are misdiagnosed with Type 1 diabetes.
- It aims to find out how many people actually have monogenic diabetes.
- The research hopes to discover new genes that cause monogenic diabetes.
- Finding an accurate diagnosis can lead to better, more targeted treatment.
- Participation mainly involves allowing researchers to use existing health data and blood samples.
- If monogenic diabetes is identified, your care team will be informed.
¿Quién puede ser elegible?
This study is looking for young people who have been diagnosed with diabetes. To be included, you must have received your diabetes diagnosis when you were 25 years old or younger. Your doctors might have told you it was Type 1 diabetes, or they might have been unsure about the exact type.
However, you cannot take part if you have already had tests for something called 'autoantibodies' for Type 1 diabetes, and those tests came back positive. These autoantibodies are usually a sign that you do have Type 1 diabetes. The study is specifically interested in people who might not fit the typical Type 1 diabetes picture.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- Were you diagnosed with diabetes before your 26th birthday?
- Were you told you had Type 1 diabetes, or was the type of diabetes unclear?
- Have you never had a positive test for Type 1 diabetes autoantibodies?
- Are you willing for your anonymised health data and samples to be used for research?
¿En qué consiste la participación?
If you take part in this study, the researchers will primarily use existing health information and stored blood samples. You will not need to attend extra visits or take any new medications. The main step for you would involve giving permission for your medical records and possibly a blood sample (if one is available from your past care) to be used for genetic testing. The researchers will be looking for specific genetic changes related to monogenic diabetes. They will also look at other details like your age when you developed diabetes, family history, and insulin doses. If a genetic change linked to monogenic diabetes is found, your medical team will be informed. The total duration of your individual participation in terms of active involvement would be minimal, mainly concerning the initial consent.
Riesgos y beneficios potenciales
Ubicaciones (1)
- The Montreal Children's HospitalCódigo postal verificadoMontreal, Canadá· Reclutamiento
Preguntas comunes
What is monogenic diabetes?
Monogenic diabetes is a type of diabetes caused by a change in a single gene. It's different from Type 1 and Type 2 diabetes, which are caused by multiple factors.
Why is it important to know if I have monogenic diabetes?
Knowing you have monogenic diabetes can change your treatment. Sometimes, people with monogenic diabetes can switch from insulin injections to tablets, or they might need different doses of medication.
How is monogenic diabetes diagnosed?
It's usually diagnosed through a special blood test called genetic testing, which looks for specific changes in your genes.
Will I have to take any new medicines for this study?
No, this study does not involve taking any new medications. It mainly involves looking at your medical information and possibly existing blood samples.
What happens if they find a genetic change linked to monogenic diabetes in me?
If they find a relevant genetic change, the results will be shared with your diabetes care team, who can then discuss what this means for your diagnosis and treatment.
Cómo obtener más información
Constantin Polychronakos, MD
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
¿Interesado en participar?
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.